Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/8/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 1.01M
-168.11x13.93x-190.67x-.--% 40B
19.93x1.91x11.03x1.02% 23.53B
17.02x1.33x7.56x5.11% 7.28B
352.56x - - - 5.41B
46.67x8.3x29.49x1.11% 2.89B
-22.52x - - - 2B
-34.01x - - -.--% 1.97B
31.71x1.13x9.45x0.8% 1.82B
12.36x1.29x5.07x6.12% 1.65B
Average 28.40x 4.65x -21.35x 2.02% 8.66B
Weighted average by Cap. -47.65x 8.30x -93.32x 0.96%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited